CSS LLC’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-18,200
Closed -$300K 821
2016
Q3
$300K Buy
18,200
+7,300
+67% +$108K 0.01% 480
2016
Q2
$146K Hold
10,900
0.01% 599
2016
Q1
$167K Hold
10,900
0.01% 543
2015
Q4
$216K Hold
10,900
0.01% 544
2015
Q3
$190K Hold
10,900
0.01% 594
2015
Q2
$220K Hold
10,900
0.01% 642
2015
Q1
$192K Hold
10,900
0.01% 616
2014
Q4
$177K Hold
10,900
0.01% 654
2014
Q3
$241K Hold
10,900
0.01% 624
2014
Q2
$219K Hold
10,900
0.01% 627
2014
Q1
$203K Buy
+10,900
New +$150K 0.01% 566

Other funds holding AMRI

CSS LLC's AMRI Position: Q4 2016 in Review

CSS LLC sold out of Albany Molecular Research Inc (AMRI) in Q4 2016, closing a stake of 18,200 shares — an estimated $300K sold.

CSS LLC first reported a position in AMRI in Q1 2014 and held it in 11 quarters. The position peaked at $300K in Q3 2016. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • CSS LLC reported no remaining Albany Molecular Research Inc position as of Q4 2016 after selling out during the quarter.
  • CSS LLC sold 18,200 Albany Molecular Research Inc shares in Q4 2016, an estimated $300K.
  • CSS LLC first reported a position in Albany Molecular Research Inc in Q1 2014 and held it in 11 quarters.
  • CSS LLC's Albany Molecular Research Inc position peaked at $300K in Q3 2016.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on CSS LLC's 13F filing for Q4 2016, filed 14 Feb 2017.